These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4330067)

  • 21. Biofilm-forming ability and infection potential of Pseudomonas aeruginosa strains isolated from animals and humans.
    Milivojevic D; Šumonja N; Medic S; Pavic A; Moric I; Vasiljevic B; Senerovic L; Nikodinovic-Runic J
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29684116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.
    Liu PV
    J Infect Dis; 1966 Oct; 116(4):481-9. PubMed ID: 4959184
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
    Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular toxins of Pseudomonas aeruginosa.
    Liu PV
    J Infect Dis; 1974 Nov; 130 Suppl(0):S94-9. PubMed ID: 4370620
    [No Abstract]   [Full Text] [Related]  

  • 25. Toxinogenicity and markers of pathogenicity of Pseudomonas aeruginosa strains isolated from patients with tumor diseases.
    Majtán V; Hostacká A; Majtánová L; Trupl J
    Folia Microbiol (Praha); 2002; 47(4):445-9. PubMed ID: 12422526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Enzymes of the pathogenicity of Bacillus pyocyaneus].
    Zhukova EG
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Dec; 44(12):129. PubMed ID: 4240291
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.
    Holder IA; Haidaris CG
    Can J Microbiol; 1979 May; 25(5):593-9. PubMed ID: 89891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa elastase and its role in pseudomonas infections.
    Wretlind B; Pavlovskis OR
    Rev Infect Dis; 1983; 5 Suppl 5():S998-1004. PubMed ID: 6419322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The cytopathic effect induced by strains of Pseudomonas aeruginosa producing hemolysin, leukocidin and proteases in Hep-2 cells].
    Zanetti S; Cappuccinelli P; Fadda G
    Boll Ist Sieroter Milan; 1986; 65(3):237-41. PubMed ID: 3096348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An epidemiological study of Pseudomonas aeruginosa infection. An epidemiological study of the clinical and environmental strains in the urological field (author's transl)].
    Kamada H
    Nihon Hinyokika Gakkai Zasshi; 1979 Oct; 70(10):1142-58. PubMed ID: 118296
    [No Abstract]   [Full Text] [Related]  

  • 31. Characteristics of Pseudomonas aeruginosa strains isolated from urinary tract infections.
    Puzová H; Siegfried L; Kmetová M; Durovicová J; Kerestesová A
    Folia Microbiol (Praha); 1994; 39(4):337-41. PubMed ID: 7729771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease.
    Brodinova NS; Moroz AF; Luchina TYa
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):69-76. PubMed ID: 6406591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence and resistance features of Pseudomonas aeruginosa strains isolated from chronic leg ulcers.
    Georgescu M; Gheorghe I; Curutiu C; Lazar V; Bleotu C; Chifiriuc MC
    BMC Infect Dis; 2016 Mar; 16 Suppl 1(Suppl 1):92. PubMed ID: 27169367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease.
    Liu PV
    J Infect Dis; 1966 Feb; 116(1):112-6. PubMed ID: 4956054
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum sensitivity of Pseudomonas aeruginosa isolated from sputum as a virulence factor in the lower respiratory tract].
    Sonoda F; Oishi K; Tanaka H; Hideaki M; Kobayashi S; Nagatake T; Matsumoto K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jun; 29(6):703-9. PubMed ID: 1910122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathogenicity of clinical strains of Pseudomonas aeruginosa].
    Savitskaia KI; Levina EN; Sinitsina GG
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Jun; (6):84-9. PubMed ID: 111443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water.
    Silva ME; Filho IC; Endo EH; Nakamura CV; Ueda-Nakamura T; Filho BP
    Antonie Van Leeuwenhoek; 2008 May; 93(4):323-34. PubMed ID: 18038252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A STUDY OF FEATURES USED IN THE DIAGNOSIS OF PSEUDOMONAS AERUGINOSA.
    COLWELL RR
    J Gen Microbiol; 1964 Nov; 37():181-94. PubMed ID: 14247743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.